Please try another search
For the six months ended 31 March 2022, Asian Healthcare Specialists Ltd revenues increased 4% to SP$13.8M. Net income increased 41% to SP$2.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Share of loss of associate decrease of 70% to SP$91K (expense), Depreciation decrease of 2% to SP$561K (expense).
Period Ending: | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
---|---|---|---|---|
Total Revenue | 13.82 | 14.21 | 13.35 | 10.25 |
Gross Profit | 11.68 | 12.04 | 11.2 | 8.71 |
Operating Income | 3.59 | 4.03 | 4.5 | 3.32 |
Net Income | 2.87 | 2.45 | 2.03 | 1.56 |
Period Ending: | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
---|---|---|---|---|
Total Assets | 67.52 | 61.73 | 60.27 | 58.8 |
Total Liabilities | 10.67 | 11.08 | 11.84 | 11.61 |
Total Equity | 56.86 | 50.66 | 48.43 | 47.18 |
Period Ending: | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | 3.08 | 8.66 | 3.23 | 5.18 |
Cash From Investing Activities | -0.15 | -0.16 | -0.13 | -12.51 |
Cash From Financing Activities | 1.83 | -5.9 | -2.19 | 0.24 |
Net Change in Cash | 4.76 | 2.6 | 0.91 | -7.09 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review